NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
| Source: | Find a Tender Service (FTS) |
| Buyer: | NHS England |
| Main Category: | Goods |
| Procurement Method: | Open procedure |
| Tender Status: | Active |
| Estimated Value (ex. VAT): | £877,670,570 |
| Estimated Value (inc. VAT): | £1,053,204,684 |
| Release Date: | 17 March 2026 |
| Application Deadline: | 17 April 2026 |
| Enquiry Deadline: | 10 April 2026 |
| Contract Start Date: | 31 August 2026 (Estimated) |
| Contract End Date: | 31 August 2028 (Estimated) |
| Contract Duration: | 2.0 years |
| Procurement ID (OCID): | ocds-h6vhtk-051c98🔒 BidWriter |
| Notice Reference: | 023990-2026🔒 BidWriter |
Ready to bid on this contract?
BidWriter AI writes your tender response in minutes — import this contract in one click.
View Original Notice
Access the full notice on the official portal
Description
NHS Branded Framework Agreement – Lot 1 - Tranche A for the North of England and Midlands & East. Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months. Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.
Links & Documents
Apply Online
Proceed to the official portal to submit your bid.
Pipeline status
Not addedContract imported automatically · AI writes the response
Assign to team member
Delegate this bid in BidWriter
Run Bid / No Bid analysis
Score this opportunity in BidWriter
Sign in to BidWriter to sync favourites across devices
Application Deadline
17 April 2026
5 days left
Estimated Value
£877,670,570
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →